What are the drugs for Parkinson's disease

summary

What are the drugs for Parkinson's disease? My grandfather used to be in good health. But during this period of time, I found that his action became a little slow. Sometimes I called him. If he looked back at me, it would take him half a day to turn his head around. And feel his movement appeared trembling situation, holding chopsticks when the hand is also trembling, clip vegetables always can't clip up.

What are the drugs for Parkinson's disease

One: anticholinergic drugs: mainly by inhibiting the activity of acetylcholine in the brain, the corresponding increase in dopamine effect. Clinical commonly used is benhexol hydrochloride, 1-2mg, three times a day. It is mainly suitable for patients with obvious tremor and younger age. The main adverse reactions were dry mouth, blurred vision, constipation, dysuria, affecting intelligence, hallucination and delusion in severe cases.

Second: amantadine: can promote the synthesis and release of dopamine in nerve endings, prevent its re absorption. It may be effective for dyskinesia. 50-100mg, 2-3 times a day, the last time should be taken before 4 pm. Adverse reactions were restless legs, blurred vision, lower limb reticular plaques, ankle edema, etc., which were rare. Patients with renal insufficiency, epilepsy, severe gastric ulcer and liver disease should be cautious. It is forbidden for lactating women.

Third: monoamine oxidase B (MAO-B) inhibitors: by irreversibly inhibiting MAO-B in the brain, blocking the degradation of dopamine, relatively increasing the content of dopamine to achieve the purpose of treatment. MAO-B inhibitor can be used as a single drug in the treatment of new onset and young patients with Parkinson's disease, and it can also assist compound levodopa in the treatment of advanced patients. It may have neuroprotective effect, so early use is recommended in principle.

matters needing attention

Parkinson's incidence rate will also change with the season. For example, in this season, Parkinson's incidence rate is relatively high. We should control Parkinson's development from two aspects of medicine and diet.